Human Recombinant NAP-2 (from E. coli)
Marques : Shenandoah BiotechnologyTotal Evaluation: 0
Moyenne des Notes : 0.0 sur 5
Neutrophil activating peptide 2 (NAP-2), also known as CXCL7, is a member of the CXC family of chemokines. NAP-2 is a carboxyl-terminal fragment produced by proteolytic cleavage of the platelet basic protein (PBP). NAP-2 is released from platelets and binds to the receptors CXCR1 and CXCR2 to chemoattract and activate neutrophils during inflammatory events.
- High quality
- Low endotoxin
- Affordable
Attention: For research use only.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...